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Objective Junctional adhesion molecule (JAM)-A and JAM-C regulate leukocyte-
endothelial cell (EC) interactions. JAMs also interact at inter-EC junctions regulating 
vascular permeability and are implicated in pathophysiological processes involving leu-
kocyte transmigration, tight junction assembly and angiogenesis. SSc is characterized by 
early perivascular inflammatory infiltrates, EC damage and defective angiogenesis. We 
investigated the expression of JAMs in SSc skin and dermal microvascular ECs (MVECs) 
challenged with SSc sera.
Methods Skin biopsies were obtained from the involved skin of 16 SSc patients 
(10 early, 6 late phase) and from 10 controls. Skin sections were stained with primary 
antibodies (Abs) anti-human JAM-A or JAM-C followed by fluorochrome-conjugated 
secondary Abs. The lymphatic EC specific marker podoplanin (D2-40) was used to dif-
ferentiate blood (D2-40–) and lymphatic (D2-40+) vessels. Human dermal MVECs were 
stimulated with VEGF or early SSc (n=5) and control (n=4) sera for 1, 6, 24 h. MVECs 
were double-immunolabeled for JAM-C and the human tight junction protein zonula 
occludens-1 (ZO-1), or for JAM-A and the pro-angiogenic αVβ3 integrin. Immunostained 
tissue sections and cells were examined by CLSM. Densitometric analysis of staining 
intensity was performed using ImageJ software.
Results In control skin, constitutive expression of JAM-A was observed in blood 
and lymphatic ECs, fibroblasts and keratinocytes. In early SSc skin, JAM-A expression 
was increased in blood and lymphatic vessels and fibroblasts. Moreover, perivascular 
inflammatory cells showed strong JAM-A positivity. In late SSc, JAM-A expression was 
weaker than in controls. JAM-C was weakly expressed in controls. In early SSc, JAM-C 
expression was markedly observed in blood and lymphatic ECs, fibroblasts, and inflam-
matory cells. Instead, in late SSc JAM-C expression was similar to controls. Stimulation 
of MVECs with early SSc sera increased the cell surface expression of JAM-A and αVβ3 
integrin. JAM-C expression was found in MVEC cytoplasm at basal conditions and un-
der stimulation with control sera. Upon early SSc sera challenging, JAM-C was rapidly 
recruited to tight junctions where it colocalized with ZO-1, with the maximun effect 
after 1 h. Similar effects were observed after 1 h VEGF stimulation.
Conclusions JAMs are differentially expressed in early and late SSc skin. Early SSc 
sera affect the expression and subcellular localization of JAMs in dermal MVECs. In 
SSc, JAMs may participate in early inflammatory process, EC activation and impaired 
angiogenesis.
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